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wall, septum and posterior wall. 16 Interestingly, the reported correlation between different techniques used for fibrosis delineation is influenced by the previous history of catheter ablation, since ablated atrial tissue is more easily identifiable by MRI, contrary to the non-iatrogenic diffuse interstitial atrial fibrosis. 17 Despite recent progress in the reproducibility of left atrial fibrosis assessment, 18 inherent caveats mainly stem from the reduced thickness of the atrial wall compared with the spatial resolution of the MRI. Additional limitations that may impair image quality and accuracy in LGE quantification include subjectivity in the definition of left atrial borders during segmentation, irregular rhythm and respiration pattern, increased body mass index and other types of technical faults.
Another tool that has been proposed for the assessment of underlying fibrosis is surface ECG. The more extensive the underlying atrial fibrosis, the slower the conduction within the left atrium, resulting in a prolonged duration of the sinus P wave. Jadidi et al. have reported a correlation between the extent of left atrial low-voltage substrate, which is indicative of underlying fibrosis, and the duration of amplified sinus P wave. 19 They also proposed that a cut-off value of 150 msec identifies patients with fibrotic substrate who are also at increased risk of arrhythmia recurrence following catheter ablation of AF and offers high sensitivity and specificity. Thus, this widely available, non-invasive, low-cost tool could be used in everyday practice for the preprocedural assessment of underlying atrial fibrosis content, as well as improve the success rate of invasive arrhythmia management.
Impact on Patient Management
The evaluation of atrial fibrosis as the main indicator of underlying structural remodelling may affect decision making at several stages of the management plan of AF patients. The respective AF treatment domains that are influenced by the presence of underlying atrial fibrosis are assessment of stroke risk and need for anticoagulation; decision for rhythm control strategy; and modification of adopted strategy during catheter ablation.
Assessment of Stroke Risk and Need for Anticoagulation
Atrial fibrosis is associated with a worsened prognosis among AF In the case presented in Figure 1 , a young woman with homozygous thalassaemia and paroxysmal AF was prescribed anticoagulant treatment despite the absence of any clinical ischaemic risk factors, and solely based on the extensive atrial fibrosis identified during voltage mapping. However, despite similar anecdotal cases, adequately powered prospective studies are needed to validate the role of atrial fibrosis for guidance of antithrombotic treatment in AF patients.
Decision for Rhythm Control Strategy
The assessment of atrial fibrosis may aid in the selection of patients anticipated to gain benefit from rhythm control management. 25 Accumulating data support the notion that the higher the burden of atrial fibrosis, the more complex the underlying mechanism of AF, and thus the more challenging is sinus rhythm maintenance. Jadidi et al.
demonstrated that the mean AF cycle length is inversely related to the extent of LGE on CMR. 26 Cochet et al. found that left atrial fibrosis,
as assessed by LGE, is the only independent predictor of the number of re-entrant regions and the complexity of underlying re-entrant activity in the left atrium among persistent AF patients subjected to high-resolution electrocardiographic imaging. 27 These findings are consistent with evidence derived from experimental studies. 28, 29 Furthermore, in the clinical context, the amount of preablation atrial fibrosis, as estimated by LGE-MRI, is independently associated with the likelihood of arrhythmia recurrence. 9, 27 The left atrial wall structural remodelling stage (Utah stage) is the strongest predictor of ablation outcome in multivariate analyses. 10 Therefore, especially in the case of persistent and long-term persistent AF, a large volume of atrial fibrosis evidenced by LGE-MRI may serve as a gatekeeper to rule out patients from undergoing one or more demanding ablations in the challenging pursuit of sinus rhythm maintenance.
Impact on Ablation Strategy
A wide circumferential electrical isolation of pulmonary veins remains the cornerstone of AF ablation. 30 However, despite the need for an adjunctive ablation strategy in addition to pulmonary vein isolation to improve the low rates of sinus rhythm maintenance in patients with persistent and long-standing-persistent AF, randomised clinical trials have failed to show an additional benefit from linear lesions and ablation of complex fractionated electrograms. 31 Atrial fibrosis is an attractive target for ablation among patients with AF, as it has been proposed to participate in the complex interplay of diverse pathophysiological mechanisms. 32 Despite an existing contradiction on potential spatial correlation between re-entrant activity and underlying atrial fibrosis in AF, 27,33 several computational, experimental and human studies have supported the role of atrial fibrosis in anchoring re-entry during AF. 34, 35 The evident link between fibrotic substrate and re-entrant drivers perpetuating AF has rendered these late gadolinium enhanced areas as potential ablation targets, lending support to the development of an adjunctive ablation strategy to be implemented in addition to pulmonary vein isolation.
The first step in the incorporation of atrial fibrosis as an ablation target during invasive management of AF is the accurate identification of atrial fibrotic areas during voltage mapping. Several studies have shown a spatial correlation between low-voltage areas detected by intraprocedural voltage mapping and fibrotic areas identified by delayed enhancement cardiac MRI. 36 The evolution of 3D electroanatomic mapping tools and high-density voltage mapping improved the identification of pathological tissue. 37 However, voltage mapping during AF tends to overestimate the extent of underlying atrial fibrosis due to significant differences in electrogram voltage amplitude between sinus rhythm and AF at the same sites among persistent AF patients. 38 The optimal cut-off value for accurate demarcation of left atrial scar displays regional variation, and a bipolar voltage of 0.27 mV best identified atrial scar compared with delayed enhancement cardiac MRI. 39 The optimal ablation method of atrial fibrotic areas in the context of AF ablation has not been clarified. Several ablation strategies targeting atrial fibrotic areas have been proposed in the context of persistent AF ablation.
Box Isolation of the Fibrotic Area
The isolated fibrotic areas should also be connected to neighbouring anchoring lines, such as the circumferential pulmonary vein isolation lines or other empirical lines, including the roof line, mitral isthmus line or anterior line. 40, 41 The deployed connection lesions aim to prevent micro or macro re-entrant arrhythmias through iatrogenically formed conduction channels around the isolated fibrotic areas. This strategy of individualised substrate modification has been reported to improve the ablation success rate when applied in addition to pulmonary vein isolation during ablation of paroxysmal and non-paroxysmal AF ( Figure 2 ). 
Selective Ablation of Atrial Low-voltage Sites
A caveat of targeting all atrial fibrotic areas during substrate modification in persistent AF is the lack of specificity in identifying underlying driver re-entrant circuits or rotors. 27 In other words, the majority of pathophysiological culprit re-entrant regions are located within atrial fibrotic areas. However, several fibrotic areas do not home re-entrant circuits, and thus their ablation would not be expected to have an impact on AF organisation or termination. 27 Therefore, it seems intriguing to select the low-voltage areas to be targeted during ablation 
Electroanatomical mapping was performed during scheduled catheter ablation for this woman with thalassaemia major (beta thalassaemia homozygous state) and early persistent AF. She had no clinical thromboembolic risk factors and a CHA 2 DS 2 -VASc score of 1 due to her gender. The voltage map was performed in sinus rhythm and demonstrated extensive fibrosis using strict voltage criteria for identification of 'scar' (≤0.2 mV). Viable tissue was identified only in 17.6% of the left atrial surface. Based on these procedural findings, no ablation lesions were deployed, a rate-control strategy was adopted, and anticoagulant therapy was recommended in contradiction to the current guidelines.
Clinical Arrhythmias (>70% of AF cycle length), repetitive rotational activity or discrete rapid activity. 45 The same group demonstrated that the ablation of those sites in addition to pulmonary vein isolation was associated with significantly reduced recurrence of atrial tachyarrhythmias compared with pulmonary vein isolation only. 45 Furthermore, targeted ablation of specific electrograms in low-voltage areas in addition to wide antral circumferential ablation in patients with persistent AF has been reported to improve patient outcome. 
Conclusion
The role of atrial fibrosis in the maintenance of persistent AF is well established. Despite our progress in accurately identifying the presence, location and extent of atrial fibrosis, there are gaps in understanding the optimal way of targeting those fibrotic areas of interest during catheter ablation. Diverse existing ablation strategies aiming to modify the arrhythmogenic substrate and to improve the outcome of patients with persistent AF subjected to catheter ablation need to be tested in adequately powered prospective, multicentre studies. These findings are expected to pave the way towards more effective invasive management of AF.
Clinical Perspective
• Left atrial fibrosis is independently associated with history of stroke and is a risk factor for future thromboembolic events.
Evaluation of atrial fibrosis might improve thromboembolic risk stratification.
• Substrate-modification strategies targeting low-voltage areas in the left atrium may improve the long-term outcome of AF ablation. 
